美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

First Tracks Biotherapeutics Inc

17.18

+0.42002.51%

盘后：17.180.00000.00%16:10 EDT

成交量：31.85万

成交额：549.54万

市值：5.97亿

市盈率：-3.54

高：18.10

开：17.04

低：16.80

收：16.76

52周最高：26.80

52周最低：14.79

股本：3,474.88万

流通股本：3,474.88万

量比：0.85

换手率：0.92%

股息：- -

股息率：- -

每股收益(TTM):-4.8542

净资产收益率：-48.91%

总资产收益率：-28.97%

市净率：2.32

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

First Tracks Biotherapeutics公布2026年第一季度财务业绩并更新业务进展

First Tracks Biotherapeutics公司：售股股东或可出售高达10.5股普通股 - SEC文件披露

美国研究综述-Alphabet、高露洁-棕榄、Welltower

Piper Sandler首予First Tracks Biotherapeutics增持评级目标价54美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TRAX"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":17.18,"timestamp":1779480000000,"preClose":16.76,"halted":0,"volume":318536,"hourTrading":{"tag":"盘后","latestPrice":17.18,"preClose":17.18,"latestTime":"16:10 EDT","volume":5578,"amount":95830.04,"timestamp":1779480605159,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.025059665871121607,"floatShares":34748800,"shares":34748800,"eps":-4.854211,"marketStatus":"休市中","change":0.42,"latestTime":"05-22 16:00:00 EDT","open":17.04,"high":18.1,"low":16.8,"amount":5495357,"amplitude":0.077566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.854211,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":16.76,"preHourTrading":{"tag":"盘前","latestPrice":16.65,"preClose":16.76,"latestTime":"07:57 EDT","volume":35,"amount":582.75,"timestamp":1779451041766,"change":-0.11,"changeRate":-0.006563,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":17.18,"preClose":17.18,"latestTime":"16:10 EDT","volume":5578,"amount":95830.04,"timestamp":1779480605159,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8519761737224184,"impliedVol":0.6995,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":0.8519761737224184,"shares":34748800,"dividePrice":0,"high":18.1,"amplitude":0.077566,"preClose":16.76,"low":16.8,"week52Low":14.79,"pbRate":"2.32","week52High":26.8,"institutionHeld":0,"latestPrice":17.18,"eps":-4.854211,"divideRate":0,"volume":318536,"delay":0,"ttmEps":-4.854211,"open":17.04,"prevYearClose":20,"prevWeekClose":16.9,"prevMonthClose":23.27,"prevQuarterClose":20,"fiveDayClose":16.9,"twentyDayClose":18.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1777867200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-05-22","current":-3.539195,"percent":0.9,"low":-4.945978,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"high":-3.330098,"avg":-3.986057,"sd":0.449538,"marketCap":584796305},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305}],"updateTime":1779660101523},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1102003350","title":"First Tracks Biotherapeutics公布2026年第一季度财务业绩并更新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1102003350","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102003350?lang=zh_cn&edition=fundamental","pubTime":"2026-05-15 04:16","pubTimestamp":1778789777,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics Inc. 近日公布了其截至2026年第一季度的财务业绩，并向市场同步更新了公司最新的业务动态。此次发布涵盖了公司在关键研发项目上的推进情况、管线布局的调整以及未来的战略规划，旨在为投资者提供全面的运营视角。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137960030","title":"First Tracks Biotherapeutics公司：售股股东或可出售高达10.5股普通股 - SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1137960030","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137960030?lang=zh_cn&edition=fundamental","pubTime":"2026-05-09 04:40","pubTimestamp":1778272801,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的一份文件显示，First Tracks Biotherapeutics Inc的现有售股股东，可能将出售高达10.5股公司普通股。\n这份文件揭示了股东潜在的股份出售计划，相关信息已按监管要求进行备案。具体细节可在相关SEC文件中查阅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632818936","title":"美国研究综述-Alphabet、高露洁-棕榄、Welltower","url":"https://stock-news.laohu8.com/highlight/detail?id=2632818936","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632818936?lang=zh_cn&edition=fundamental","pubTime":"2026-05-04 15:35","pubTimestamp":1777880141,"startTime":"0","endTime":"0","summary":"美国研究综述-Alphabet、高露洁-棕榄、Welltower路透5月4日 - 周一，华尔街的证券分析师们调整了多家在美国上市公司的评级和目标股价，其中包括Alphabet、高露洁-棕榄和Welltower。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL4T41H0EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPY","AMZN","ESS","MLM","FICO","AMGN","CNC","DECK","FTAI","BTSG","MSFT","BOBS","BLDR","CL","KEX","FLS","GDDY","AX","CHD","CORZ","DAR","AAPB","AMZZ","AAPL","AMZY","CSGP","EL","ESPR","TRAX","AMZU","AAPX","DAVE","HSY","ACA","SAM","APLY","CAH","AAPD","LEA","MTCH","META","CBOE","ETSY","GOOGL","AAPW","WELL","AXSM","AMP","AAPU","MTZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166118707","title":"Piper Sandler首予First Tracks Biotherapeutics增持评级 目标价54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166118707","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166118707?lang=zh_cn&edition=fundamental","pubTime":"2026-05-04 11:36","pubTimestamp":1777865787,"startTime":"0","endTime":"0","summary":"投行Piper Sandler首次覆盖生物技术公司First Tracks Biotherapeutics，给予\"增持\"评级，并设定54美元的目标股价。\n该评级反映出分析师对该公司研发管线前景的乐观预期。目标价的设定基于对其创新疗法的估值评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TRAX\",params:#limit:6,delay:false,,,undefined,":[]}}